Joshua Stokar

Acute renal failure with sodium-glucose-cotransporter-2 inhibitors: Analysis of the FDA adverse event report system database

Amichai Perlman, Samuel N. Heyman, Ilan Matok et al. · Nutrition Metabolism and Cardiovascular Diseases · 2017 · 91 citations

Medicine, Nephrology, Pharmacology +12

Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study

Joshua Stokar, Auryan Szalat · The Journal of Clinical Endocrinology & Metabolism · 2024 · 42 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Risk of Suicidal Ideation or Attempts in Adolescents With Obesity Treated With GLP1 Receptor Agonists

Liya Kerem, Joshua Stokar · JAMA Pediatrics · 2024 · 34 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study

Michal Shauly‐Aharonov, Asher Shafrir, Ora Paltiel et al. · PLoS ONE · 2021 · 25 citations · Full text

Veterinary Medicine, Infectious Diseases, Disease Prevention +16

Hepatic adropin is regulated by estrogen and contributes to adverse metabolic phenotypes in ovariectomized mice

Joshua Stokar, Irina Gurt, Einav Cohen‐Kfir et al. · Molecular Metabolism · 2022 · 22 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17